FORT WORTH, Texas, Feb. 23 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced today that its secure data delivery and messaging subsidiary Secure eHealth, LLC has appointed Roger Fallows as Vice President of Sales. In this role Roger will lead the sales department by continuing to pursue the numerous opportunities and partnerships that have evolved since the acquisition of Secure eHealth by Wound Management earlier this month. "Roger is a dynamic and highly experienced sales professional with deep roots in the healthcare space," said Robert Tapales, President of Secure eHealth. "We are all very pleased to have him on board to help execute the aggressive sales strategy planned for the company this year," Tapales continues.
Prior to joining Secure eHealth, Roger was a senior sales executive with Oracle responsible for enterprise (ERP) solution sales into Fortune 500 companies across multiple vertical markets. He also has held sales leadership positions at a variety of leading organizations, including Oracle, SAP, Lawson, Siemens, and N.E.I.C., which was one of the original and largest healthcare clearinghouses for claims in the nation.
A large part of Secure eHealth's business development strategy for 2010 revolves around partnerships with various HIE (health information exchange) providers and community based healthcare networks. These alliances are expected to provide a solid foundation for Secure eHealth to accomplish its mission of promoting collaborative healthcare delivery by creating platforms where healthcare practitioners, ancillary providers, medical facilities and patients can freely share information safely and securely.
For information on Secure eHealth, LLC go to www.secureehealth.com
For Wound Management Technologies Shareholder Information please call 954-357-0614 or go to http://www.woundmanagementtechnologies.com
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM - News), with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida is a rapidly growing provider of specialty medical products, advanced biotechnology solutions and technology applications to secure healthcare data delivery and messaging. The Company is following the lead of NASDAQ Biotech Stock INDEX leaders such as Celgene http://www.celgene.com, Geron http://www.geron.com, and Human Genome Sciences http://www.hgsi.com by working to leverage its existing technology and infrastructure to develop opportunities within the International Biotechnology and Genetic Engineering fields. WNDM also has an interest in Cancer Treatment. For more information on the Company please visit http://www.woundmanagementtechnologies.com
About Secure eHealth, LLC
Secure eHealth, LLC is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTCBB: WNDM) and is a secure messaging and data delivery solutions provider for the public/private and government healthcare sector. Secure eHealth's mission is to encourage collaborative healthcare delivery by creating platforms where healthcare practitioners, ancillary providers, medical facilities and patients can freely share information safely and securely. For more information about Secure eHealth, LLC go to www.secureehealth.com.
Safe Harbor Statement:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
For Further Information:
Shareholder Relations-Communications 954-357-0614
SOURCE Wound Management Technologies, Inc.
Advertisement
Prior to joining Secure eHealth, Roger was a senior sales executive with Oracle responsible for enterprise (ERP) solution sales into Fortune 500 companies across multiple vertical markets. He also has held sales leadership positions at a variety of leading organizations, including Oracle, SAP, Lawson, Siemens, and N.E.I.C., which was one of the original and largest healthcare clearinghouses for claims in the nation.
Advertisement
A large part of Secure eHealth's business development strategy for 2010 revolves around partnerships with various HIE (health information exchange) providers and community based healthcare networks. These alliances are expected to provide a solid foundation for Secure eHealth to accomplish its mission of promoting collaborative healthcare delivery by creating platforms where healthcare practitioners, ancillary providers, medical facilities and patients can freely share information safely and securely.
For information on Secure eHealth, LLC go to www.secureehealth.com
For Wound Management Technologies Shareholder Information please call 954-357-0614 or go to http://www.woundmanagementtechnologies.com
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM - News), with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida is a rapidly growing provider of specialty medical products, advanced biotechnology solutions and technology applications to secure healthcare data delivery and messaging. The Company is following the lead of NASDAQ Biotech Stock INDEX leaders such as Celgene http://www.celgene.com, Geron http://www.geron.com, and Human Genome Sciences http://www.hgsi.com by working to leverage its existing technology and infrastructure to develop opportunities within the International Biotechnology and Genetic Engineering fields. WNDM also has an interest in Cancer Treatment. For more information on the Company please visit http://www.woundmanagementtechnologies.com
About Secure eHealth, LLC
Secure eHealth, LLC is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTCBB: WNDM) and is a secure messaging and data delivery solutions provider for the public/private and government healthcare sector. Secure eHealth's mission is to encourage collaborative healthcare delivery by creating platforms where healthcare practitioners, ancillary providers, medical facilities and patients can freely share information safely and securely. For more information about Secure eHealth, LLC go to www.secureehealth.com.
Safe Harbor Statement:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
For Further Information:
Shareholder Relations-Communications 954-357-0614
SOURCE Wound Management Technologies, Inc.
